Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
Ethnicity & Disease
|
June 16, 2006
A crash-course in cultural competence
George Rust, Kofi Kondwani, Ruben Martinez, et al.
Seminars in Oncology
|
December 18, 2020
A double-edged sword: Prolonged detection of SARS-COV-2 in patients receiving cancer directed therapy
Winston Wong, Claire Brieva, Michael May, et al.
Oral Oncology
|
May 8, 2025
Defining response-adapted surgery after neoadjuvant therapy in oral cavity cancer
Jennifer R Cracchiolo, Michael T Starc, Richard J Wong, et al.
The Lancet. Oncology
|
February 5, 2026
Evaluation of progression-free status at 24 months as a surrogate endpoint for overall survival in patients with human papillomavirus-positive oropharyngeal cancer: a retrospective cohort study
Caineng Cao, Eric J Sherman, Nadeem Riaz, et al.
Oral Oncology
|
May 25, 2024
A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer
Antoine Desilets, David G Pfister, Sarah Stein, et al.
Oral Oncology
|
June 30, 2026
Characterization of response-adapted surgery following neoadjuvant systemic therapy in oral cavity cancer
Richard J Lu, Lara Dunn, Kenric Tam, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 1, 2020
Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma
Akimasa Hayashi, Aslihan Yavas, Caitlin A McIntyre, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
October 17, 2025
Pathologic Response to Neoadjuvant Cetuximab, Platinum, and Taxane in Locally Advanced HNSCC
Gabriel Raab, Bin Xu, Anas Alabkaa, et al.
Oral Oncology
|
September 3, 2025
A phase 1/1b study of lenvatinib and cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma
Lara A Dunn, Alan L Ho, Loren S Michel, et al.
Head & Neck
|
October 21, 2025
Proton Therapy for Paranasal Sinus Cancer: Clinical Outcomes and Patterns of Failure
Caineng Cao, Teeradon Treechairusame, Nadeem Riaz, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
Ethnicity & Disease
|
June 16, 2006
A crash-course in cultural competence
George Rust, Kofi Kondwani, Ruben Martinez, et al.
Seminars in Oncology
|
December 18, 2020
A double-edged sword: Prolonged detection of SARS-COV-2 in patients receiving cancer directed therapy
Winston Wong, Claire Brieva, Michael May, et al.
Oral Oncology
|
May 8, 2025
Defining response-adapted surgery after neoadjuvant therapy in oral cavity cancer
Jennifer R Cracchiolo, Michael T Starc, Richard J Wong, et al.
The Lancet. Oncology
|
February 5, 2026
Evaluation of progression-free status at 24 months as a surrogate endpoint for overall survival in patients with human papillomavirus-positive oropharyngeal cancer: a retrospective cohort study
Caineng Cao, Eric J Sherman, Nadeem Riaz, et al.
Oral Oncology
|
May 25, 2024
A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer
Antoine Desilets, David G Pfister, Sarah Stein, et al.
Oral Oncology
|
June 30, 2026
Characterization of response-adapted surgery following neoadjuvant systemic therapy in oral cavity cancer
Richard J Lu, Lara Dunn, Kenric Tam, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 1, 2020
Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma
Akimasa Hayashi, Aslihan Yavas, Caitlin A McIntyre, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
October 17, 2025
Pathologic Response to Neoadjuvant Cetuximab, Platinum, and Taxane in Locally Advanced HNSCC
Gabriel Raab, Bin Xu, Anas Alabkaa, et al.
Oral Oncology
|
September 3, 2025
A phase 1/1b study of lenvatinib and cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma
Lara A Dunn, Alan L Ho, Loren S Michel, et al.
Head & Neck
|
October 21, 2025
Proton Therapy for Paranasal Sinus Cancer: Clinical Outcomes and Patterns of Failure
Caineng Cao, Teeradon Treechairusame, Nadeem Riaz, et al.
Page
of 6